◆ SpookStack

hori 1D 4 18144] [ShS42 141553 1a0759 10760 150761 151762 131763 151764 151765 1S 13a 151767 LS 7a8 [S869 1SL7 0 ISITTI TS h7T2 151773 Pub Date OUON9St OM o387 UR 04/12/1959 O51 1959 O51 3/1959 OS 11959 O09! 1959 Lia 195¢ TV ES1os9 PAGS 959 11201959 LOL oso T2F TO Pgs P2FLPAISEo 22401959 O25") Sot O25 10 Pages Document Title (ESTIMATED PUB DATE) (LINTITLED) RE DESCRIPTION OF DRUGS AND ITS EFFECT ON PEOPLE ANNUAL PROGRESS REPORT PREPARED AY HARRIS ISBELL - | JANUARY 1986 TO 31 DECMERER 1956 (ESTIMATED PUB DATE) ADDICTION LIABILITIES OF SYNTHETIC SUBSTITUTES FOR CODEINE D-DIHYDRO-LYSERGIC ACID DIETHYLAMIDE (¥-A-24) (ESTIMATED PUB DATE} 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE TARTRATE (UML-491, V- A-23). ELYMOCLAYVINE (43-¥), CROSS TOLERANCE BETWEEN LSD-25 AND PSILOCY BIN. LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH RE i{BETA-DIETHYLAMINOETH ¥YL}-2-(F- ETHOXY BBENZYL)-5-NITROBENZIMIDAZOLE METHANE SULFONATE (FA-20484, NIH-7607, ARC 1- G-2) WITHOUT ENCLOSURES I, PROGRESS REPORT ABSTRACT, TASK NO. NR IOL-149, CONTRACT NAON R- 14-60, 2. REQUEST FOR RENEWAL OF PROJECT, JULY 1960 THROUGH JUNE i961, 3. MEMORANDUM TO MR. LEONARD M. LIBBER, HEAD, PHYSIOLOGY BRANCH, ONR WITHOUT ENCLOSURES |, PROGRESS REPORT ABSTRACT, TASK NO. NR 101-149, CONTRACT NAONR- 14-60, 2. REQUEST FOR RENEWAL OF PROJECT, JULY 1960 THROUGH JUNE 1961 WITHOUT ENCLOSURE (ESTIMATED PUB DATE) THE ADDICTION LIABILITIES OF SYNTHETIC SUBSTITUTES FOR CODEINE WITH ENCLOSED PROJECT DESCRIPTION AND ATTACHMENT LETTER FROM HARRIS ISBELL TO WORLD HEALTH ORGANIZATION RE HIS ADDRESS AND TELEPHONE NUMBER {ESTIMATED PUB DATE} LETTER TO DR. HARRIS [SHELL RE SETTING ESTABLISHING A TELEPHONE CONVERSATION IN DECEMBER WITH (DELETED) ON A MATTER OF MUTUAL INTEREST (ESTIMATED PUB DATE) LETTER TO OR. HARRIS ISHELL FROM RAY RE TRANSMITTAL OF PACKAGE AND REQUEST FOR INFORMATION ON THE BENZIMIDAZOLE DERIVATIVE LETTER TO RAY FROM ISBELL HARRIS RE TEMPORARY MAILING ADDRESS LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH RE PRESENTATION OF PAPER TITLED “USE OF A BENZIMIDAZOLE DERIVATIVE WITH POTENT MORPHINE-LIKE PROPERTIES ORALLY AS A PRESUMPTION REINFORCER IN CONDITIONING OF DRUG-SEEKING BEHAVIOR IN RATS" WITHOUT ENCLOSUBE LETTER TO DR. RUDOLF RICHER (SANOZ PHARMA CEUTICALS) FROM ABRAHAM WIKLER RE PSILOCTYBIN AND LSD-24 WITH ENCLOSURES LETTER TO NATIONAL INSTITUTE OF MENTAL HEALTH FROM ABRAHAM WIKLER RE LETTER & STUDY RESULTS SENT TO DR, R. BIRCHER (SANDOZ, INCORPORATED) RE PSILOCYBIN AND LSD- ih Dawe 9